|4Jan 10, 6:36 PM ET

Jene Jill M. 4

4 · PDL BIOPHARMA, INC. · Filed Jan 10, 2020

Insider Transaction Report

Form 4
Period: 2020-01-08
Jene Jill M.
VP, Business Development
Transactions
  • Award

    Common stock

    2020-01-08+194,805194,805 total
Footnotes (1)
  • [F1]The restricted stock units will vest as follows: (a) 40% of the shares subject to the award shall vest on the one year anniversary of the grant date and (b) 2.5% of the shares subject to the award shall vest monthly thereafter; provided that the recipient's continuous service has not terminated prior to the applicable vesting date, subject to earlier vesting upon a change in control and certain qualifying terminations of employment provided in the severance and retention plans covering the participant.

Documents

1 file
  • 4
    wf-form4_157869934395847.xmlPrimary

    FORM 4